Korean researchers develop biosensor to measure serotonin levels in real-time
A research team from the Korea Research Institute of Bioscience and Biotechnology has developed a biosensor that can track serotonin levels in real time for the diagnosis of depression.
Depression, which affects over a million South Koreans, is believed to be partly caused by imbalances in the level of neurotransmitters...
AI startup FathomX from Singapore has raised SG$2.24 million ($1.6 million) from an undisclosed investor in the lead-up to its Series A funding round.
This follows its seed funding round in April last year where it raised SG$500,000 (over $350,000).
WHAT IT DOES
A spin-off from the National University of Singapore and the National University Health System, FathomX offers an AI-powered...
Indonesian digital pharmacy Lifepack scores $7M in Series A funding
Lifepack, a digital pharmacy in Indonesia, has raised $7 million in a Series A funding round led by Golden Gate Ventures.
Launched in 2020, the mobile health platform offers quality and cheap medicines, including over-the-counter drugs, general supplements, and medication for chronic illnesses. Available on Android and iOS...
Singapore-based health technology company MiyaHealth has received an undisclosed sum of investment from HealthXCapital, Central Capital Ventura, and SEEDS Capital.
This comes on top of the $4.8 million it raised in a pre-Series A round earlier this year.
Founded in 2019, the startup offers two technology platforms: MiyaPatient, a navigation platform that helps patients manage their chronic...
Singapore's Health Services Authority has approved for commercialisation an AI-enabled implantable cardiac device by Hydrix Medical, the medical technology business of ASX-listed company Hydrix.
WHAT IT DOES
The device called Guardian is a heart monitor implanted in the same manner as a single-chamber pacemaker. Unlike a pacemaker, this device monitors the heart's electric signal round the clock...
IIT Delhi researchers develop algorithms that detect epileptic seizure source
Researchers from the Indian Institute of Technology – Delhi have come up with a novel algorithm that can localise the epileptogenic zone using a patient's EEG data.
In cases of drug-resistant epilepsies, neurosurgeons have to first determine the exact origin and extent of structural abnormalities in a patient's brain...
Indian EMR platform HealthPlix launches drug-drug interaction feature
Indian EMR startup HealthPlix Technologies has gone live with a new drug-to-drug interaction feature on its platform.
The new tool on the HealthPlix EMR is said to reduce the time taken in writing prescriptions by assisting doctors in recalling molecule-to-molecule interactions at the point of care.
Before, doctors have to rely...
Intellect announced last Tuesday that it has raised another $10 million in a Series A extension, bringing the Series A total to $20 million after its launch two years ago.
Following a funding round led by Tiger Global, the mental health startup said in a press statement that "the additional capital makes this the largest venture round raised by any mental health company in Asia".
In a statement...
Oncoshot receives funding to further expand in India, Australia
Singaporean medical startup Oncoshot has scored an undisclosed investment through a pre-Series A funding round led by Biofurmis and Qure.ai investor MassMutual Ventures.
Based on a press release, the funding will support the company's further expansion into India and Australia.
There are four hospital networks in India and some...
MSIG Hong Kong provides free limited-time access to mental health app Intellect
Mental health startup Intellect has partnered with MSIG Hong Kong, a member of MS&AD Insurance Group, to provide corporate wellbeing support to insurance clients.
From 4 July to 31 December, MSIG Hong Kong's SME Group Medical Insurance policyholders and applicants will have free complimentary access to Intellect's...